nodes	percent_of_prediction	percent_of_DWPC	metapath
Ondansetron—HTR1B—Penbutolol—coronary artery disease	0.059	0.0941	CbGbCtD
Ondansetron—HTR1A—Penbutolol—coronary artery disease	0.037	0.059	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Eplerenone—coronary artery disease	0.0238	0.0379	CbGbCtD
Ondansetron—CYP3A7—Eplerenone—coronary artery disease	0.0238	0.0379	CbGbCtD
Ondansetron—CYP3A5—Clopidogrel—coronary artery disease	0.0192	0.0306	CbGbCtD
Ondansetron—CYP2C9—Fenofibrate—coronary artery disease	0.0185	0.0296	CbGbCtD
Ondansetron—CYP3A5—Eplerenone—coronary artery disease	0.0178	0.0284	CbGbCtD
Ondansetron—CYP1A2—Gemfibrozil—coronary artery disease	0.0165	0.0263	CbGbCtD
Ondansetron—KCNH2—purkinje fiber—coronary artery disease	0.0162	0.341	CbGeAlD
Ondansetron—CYP3A7—Simvastatin—coronary artery disease	0.0153	0.0244	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Simvastatin—coronary artery disease	0.0153	0.0244	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Lovastatin—coronary artery disease	0.015	0.0239	CbGbCtD
Ondansetron—CYP3A7—Lovastatin—coronary artery disease	0.015	0.0239	CbGbCtD
Ondansetron—CYP2C9—Gemfibrozil—coronary artery disease	0.0148	0.0237	CbGbCtD
Ondansetron—CYP1A2—Clopidogrel—coronary artery disease	0.0143	0.0228	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Atorvastatin—coronary artery disease	0.0136	0.0218	CbGbCtD
Ondansetron—CYP3A7—Atorvastatin—coronary artery disease	0.0136	0.0218	CbGbCtD
Ondansetron—CYP2C9—Clopidogrel—coronary artery disease	0.0129	0.0205	CbGbCtD
Ondansetron—CYP3A5—Rosuvastatin—coronary artery disease	0.0124	0.0197	CbGbCtD
Ondansetron—CYP3A4—Ticagrelor—coronary artery disease	0.0121	0.0193	CbGbCtD
Ondansetron—CYP3A5—Simvastatin—coronary artery disease	0.0115	0.0183	CbGbCtD
Ondansetron—CYP3A5—Pravastatin—coronary artery disease	0.0112	0.0179	CbGbCtD
Ondansetron—CYP3A5—Lovastatin—coronary artery disease	0.0112	0.0179	CbGbCtD
Ondansetron—CYP2C9—Pitavastatin—coronary artery disease	0.0112	0.0179	CbGbCtD
Ondansetron—CYP2C9—Valsartan—coronary artery disease	0.0109	0.0174	CbGbCtD
Ondansetron—CYP3A4—Fenofibrate—coronary artery disease	0.0108	0.0172	CbGbCtD
Ondansetron—CYP3A5—Atorvastatin—coronary artery disease	0.0102	0.0163	CbGbCtD
Ondansetron—CYP3A5—Losartan—coronary artery disease	0.00936	0.0149	CbGbCtD
Ondansetron—CYP2D6—Niacin—coronary artery disease	0.00891	0.0142	CbGbCtD
Ondansetron—CYP3A4—Gemfibrozil—coronary artery disease	0.00862	0.0138	CbGbCtD
Ondansetron—KCNH2—endocardium—coronary artery disease	0.00835	0.176	CbGeAlD
Ondansetron—CYP2C9—Rosuvastatin—coronary artery disease	0.00829	0.0132	CbGbCtD
Ondansetron—CYP2D6—Timolol—coronary artery disease	0.00828	0.0132	CbGbCtD
Ondansetron—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00807	0.0129	CbGbCtD
Ondansetron—CYP2C9—Simvastatin—coronary artery disease	0.0077	0.0123	CbGbCtD
Ondansetron—CYP2C9—Lovastatin—coronary artery disease	0.00754	0.012	CbGbCtD
Ondansetron—CYP2C9—Pravastatin—coronary artery disease	0.00754	0.012	CbGbCtD
Ondansetron—CYP3A4—Clopidogrel—coronary artery disease	0.00748	0.0119	CbGbCtD
Ondansetron—CYP2D6—Captopril—coronary artery disease	0.00729	0.0116	CbGbCtD
Ondansetron—CYP2D6—Simvastatin—coronary artery disease	0.00704	0.0112	CbGbCtD
Ondansetron—CYP1A2—Losartan—coronary artery disease	0.00697	0.0111	CbGbCtD
Ondansetron—CYP3A4—Eplerenone—coronary artery disease	0.00695	0.0111	CbGbCtD
Ondansetron—CYP2D6—Pravastatin—coronary artery disease	0.00689	0.011	CbGbCtD
Ondansetron—CYP2D6—Lovastatin—coronary artery disease	0.00689	0.011	CbGbCtD
Ondansetron—CYP2C9—Atorvastatin—coronary artery disease	0.00687	0.011	CbGbCtD
Ondansetron—CYP2C9—cardial valve—coronary artery disease	0.00679	0.143	CbGeAlD
Ondansetron—CYP2C9—Losartan—coronary artery disease	0.00628	0.01	CbGbCtD
Ondansetron—CYP2D6—Atorvastatin—coronary artery disease	0.00628	0.01	CbGbCtD
Ondansetron—CYP3A4—Enalapril—coronary artery disease	0.00619	0.00988	CbGbCtD
Ondansetron—HTR3A—vagus nerve—coronary artery disease	0.00528	0.111	CbGeAlD
Ondansetron—CYP3A4—Ezetimibe—coronary artery disease	0.00482	0.00768	CbGbCtD
Ondansetron—CYP3A4—Rosuvastatin—coronary artery disease	0.00482	0.00768	CbGbCtD
Ondansetron—CYP3A4—Simvastatin—coronary artery disease	0.00448	0.00714	CbGbCtD
Ondansetron—CYP3A4—Pravastatin—coronary artery disease	0.00438	0.00699	CbGbCtD
Ondansetron—CYP3A4—Lovastatin—coronary artery disease	0.00438	0.00699	CbGbCtD
Ondansetron—CYP3A4—Atorvastatin—coronary artery disease	0.00399	0.00637	CbGbCtD
Ondansetron—CYP3A4—Losartan—coronary artery disease	0.00365	0.00582	CbGbCtD
Ondansetron—HTR1B—artery—coronary artery disease	0.00174	0.0367	CbGeAlD
Ondansetron—SLC47A1—heart—coronary artery disease	0.000752	0.0158	CbGeAlD
Ondansetron—KCNH2—cardiac ventricle—coronary artery disease	0.000703	0.0148	CbGeAlD
Ondansetron—KCNH2—myocardium—coronary artery disease	0.000661	0.0139	CbGeAlD
Ondansetron—HTR1B—cardiovascular system—coronary artery disease	0.000606	0.0128	CbGeAlD
Ondansetron—HTR3A—blood—coronary artery disease	0.000572	0.012	CbGeAlD
Ondansetron—SLC47A1—blood—coronary artery disease	0.000562	0.0118	CbGeAlD
Ondansetron—OPRM1—blood—coronary artery disease	0.000524	0.011	CbGeAlD
Ondansetron—HTR1A—cardiovascular system—coronary artery disease	0.000489	0.0103	CbGeAlD
Ondansetron—KCNH2—heart—coronary artery disease	0.000462	0.00972	CbGeAlD
Ondansetron—KCNH2—cardiovascular system—coronary artery disease	0.000436	0.00917	CbGeAlD
Ondansetron—KCNH2—cardiac atrium—coronary artery disease	0.000395	0.00831	CbGeAlD
Ondansetron—CYP2C9—heart—coronary artery disease	0.000375	0.0079	CbGeAlD
Ondansetron—CYP2C9—cardiovascular system—coronary artery disease	0.000354	0.00745	CbGeAlD
Ondansetron—KCNH2—blood—coronary artery disease	0.000345	0.00725	CbGeAlD
Ondansetron—CYP2E1—cardiovascular system—coronary artery disease	0.000336	0.00706	CbGeAlD
Ondansetron—CYP1A2—blood—coronary artery disease	0.000295	0.00621	CbGeAlD
Ondansetron—CYP3A5—blood—coronary artery disease	0.000284	0.00599	CbGeAlD
Ondansetron—CYP2C9—blood—coronary artery disease	0.00028	0.00589	CbGeAlD
Ondansetron—CYP2E1—blood—coronary artery disease	0.000265	0.00558	CbGeAlD
Ondansetron—CYP3A4—blood—coronary artery disease	0.000214	0.00449	CbGeAlD
Ondansetron—CYP2D6—blood—coronary artery disease	0.00021	0.00442	CbGeAlD
Ondansetron—Paraesthesia—Losartan—coronary artery disease	9.5e-05	0.000463	CcSEcCtD
Ondansetron—Gastrointestinal pain—Captopril—coronary artery disease	9.5e-05	0.000463	CcSEcCtD
Ondansetron—Urticaria—Telmisartan—coronary artery disease	9.49e-05	0.000462	CcSEcCtD
Ondansetron—Cough—Timolol—coronary artery disease	9.48e-05	0.000462	CcSEcCtD
Ondansetron—Vomiting—Clopidogrel—coronary artery disease	9.48e-05	0.000462	CcSEcCtD
Ondansetron—Diarrhoea—Simvastatin—coronary artery disease	9.48e-05	0.000462	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Furosemide—coronary artery disease	9.47e-05	0.000461	CcSEcCtD
Ondansetron—Chest pain—Ramipril—coronary artery disease	9.46e-05	0.000461	CcSEcCtD
Ondansetron—Fatigue—Furosemide—coronary artery disease	9.45e-05	0.000461	CcSEcCtD
Ondansetron—Tremor—Lisinopril—coronary artery disease	9.45e-05	0.00046	CcSEcCtD
Ondansetron—Abdominal pain—Telmisartan—coronary artery disease	9.44e-05	0.00046	CcSEcCtD
Ondansetron—Body temperature increased—Telmisartan—coronary artery disease	9.44e-05	0.00046	CcSEcCtD
Ondansetron—Dyspnoea—Losartan—coronary artery disease	9.43e-05	0.00046	CcSEcCtD
Ondansetron—Anxiety—Ramipril—coronary artery disease	9.43e-05	0.00046	CcSEcCtD
Ondansetron—Vomiting—Lovastatin—coronary artery disease	9.42e-05	0.000459	CcSEcCtD
Ondansetron—Somnolence—Losartan—coronary artery disease	9.41e-05	0.000458	CcSEcCtD
Ondansetron—Dizziness—Eplerenone—coronary artery disease	9.4e-05	0.000458	CcSEcCtD
Ondansetron—Rash—Clopidogrel—coronary artery disease	9.4e-05	0.000458	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	9.4e-05	0.000458	CcSEcCtD
Ondansetron—Dermatitis—Clopidogrel—coronary artery disease	9.39e-05	0.000458	CcSEcCtD
Ondansetron—Asthenia—Valsartan—coronary artery disease	9.39e-05	0.000457	CcSEcCtD
Ondansetron—Constipation—Furosemide—coronary artery disease	9.38e-05	0.000457	CcSEcCtD
Ondansetron—Pain—Furosemide—coronary artery disease	9.38e-05	0.000457	CcSEcCtD
Ondansetron—Hypersensitivity—Niacin—coronary artery disease	9.37e-05	0.000457	CcSEcCtD
Ondansetron—Ill-defined disorder—Lisinopril—coronary artery disease	9.35e-05	0.000456	CcSEcCtD
Ondansetron—Discomfort—Ramipril—coronary artery disease	9.35e-05	0.000456	CcSEcCtD
Ondansetron—Asthenia—Olmesartan—coronary artery disease	9.34e-05	0.000455	CcSEcCtD
Ondansetron—Headache—Clopidogrel—coronary artery disease	9.34e-05	0.000455	CcSEcCtD
Ondansetron—Rash—Lovastatin—coronary artery disease	9.34e-05	0.000455	CcSEcCtD
Ondansetron—Dermatitis—Lovastatin—coronary artery disease	9.33e-05	0.000455	CcSEcCtD
Ondansetron—Feeling abnormal—Perindopril—coronary artery disease	9.3e-05	0.000453	CcSEcCtD
Ondansetron—Headache—Lovastatin—coronary artery disease	9.28e-05	0.000452	CcSEcCtD
Ondansetron—Pruritus—Valsartan—coronary artery disease	9.26e-05	0.000451	CcSEcCtD
Ondansetron—Dry mouth—Ramipril—coronary artery disease	9.26e-05	0.000451	CcSEcCtD
Ondansetron—Chest pain—Timolol—coronary artery disease	9.25e-05	0.000451	CcSEcCtD
Ondansetron—Vomiting—Ezetimibe—coronary artery disease	9.24e-05	0.00045	CcSEcCtD
Ondansetron—Hypersensitivity—Pravastatin—coronary artery disease	9.23e-05	0.00045	CcSEcCtD
Ondansetron—Gastrointestinal pain—Perindopril—coronary artery disease	9.22e-05	0.000449	CcSEcCtD
Ondansetron—Anxiety—Timolol—coronary artery disease	9.22e-05	0.000449	CcSEcCtD
Ondansetron—Angioedema—Lisinopril—coronary artery disease	9.21e-05	0.000449	CcSEcCtD
Ondansetron—Pruritus—Olmesartan—coronary artery disease	9.21e-05	0.000449	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	9.19e-05	0.000448	CcSEcCtD
Ondansetron—Abdominal pain—Captopril—coronary artery disease	9.18e-05	0.000447	CcSEcCtD
Ondansetron—Body temperature increased—Captopril—coronary artery disease	9.18e-05	0.000447	CcSEcCtD
Ondansetron—Dizziness—Simvastatin—coronary artery disease	9.16e-05	0.000446	CcSEcCtD
Ondansetron—Rash—Ezetimibe—coronary artery disease	9.16e-05	0.000446	CcSEcCtD
Ondansetron—Dermatitis—Ezetimibe—coronary artery disease	9.15e-05	0.000446	CcSEcCtD
Ondansetron—Discomfort—Timolol—coronary artery disease	9.14e-05	0.000445	CcSEcCtD
Ondansetron—Asthenia—Niacin—coronary artery disease	9.13e-05	0.000445	CcSEcCtD
Ondansetron—Fatigue—Losartan—coronary artery disease	9.12e-05	0.000444	CcSEcCtD
Ondansetron—Headache—Ezetimibe—coronary artery disease	9.1e-05	0.000443	CcSEcCtD
Ondansetron—Malaise—Lisinopril—coronary artery disease	9.09e-05	0.000443	CcSEcCtD
Ondansetron—Anaphylactic shock—Ramipril—coronary artery disease	9.07e-05	0.000442	CcSEcCtD
Ondansetron—Dry mouth—Timolol—coronary artery disease	9.05e-05	0.000441	CcSEcCtD
Ondansetron—Pain—Losartan—coronary artery disease	9.05e-05	0.000441	CcSEcCtD
Ondansetron—Constipation—Losartan—coronary artery disease	9.05e-05	0.000441	CcSEcCtD
Ondansetron—Syncope—Lisinopril—coronary artery disease	9.04e-05	0.00044	CcSEcCtD
Ondansetron—Vomiting—Eplerenone—coronary artery disease	9.04e-05	0.00044	CcSEcCtD
Ondansetron—Feeling abnormal—Furosemide—coronary artery disease	9.04e-05	0.00044	CcSEcCtD
Ondansetron—Pruritus—Niacin—coronary artery disease	9e-05	0.000438	CcSEcCtD
Ondansetron—Asthenia—Pravastatin—coronary artery disease	8.99e-05	0.000438	CcSEcCtD
Ondansetron—Gastrointestinal pain—Furosemide—coronary artery disease	8.97e-05	0.000437	CcSEcCtD
Ondansetron—Rash—Eplerenone—coronary artery disease	8.96e-05	0.000437	CcSEcCtD
Ondansetron—Urticaria—Perindopril—coronary artery disease	8.96e-05	0.000437	CcSEcCtD
Ondansetron—Hypersensitivity—Trandolapril—coronary artery disease	8.96e-05	0.000437	CcSEcCtD
Ondansetron—Dermatitis—Eplerenone—coronary artery disease	8.96e-05	0.000436	CcSEcCtD
Ondansetron—Diarrhoea—Valsartan—coronary artery disease	8.95e-05	0.000436	CcSEcCtD
Ondansetron—Shock—Ramipril—coronary artery disease	8.93e-05	0.000435	CcSEcCtD
Ondansetron—Hypersensitivity—Enalapril—coronary artery disease	8.92e-05	0.000435	CcSEcCtD
Ondansetron—Body temperature increased—Perindopril—coronary artery disease	8.92e-05	0.000434	CcSEcCtD
Ondansetron—Abdominal pain—Perindopril—coronary artery disease	8.92e-05	0.000434	CcSEcCtD
Ondansetron—Palpitations—Lisinopril—coronary artery disease	8.91e-05	0.000434	CcSEcCtD
Ondansetron—Diarrhoea—Olmesartan—coronary artery disease	8.91e-05	0.000434	CcSEcCtD
Ondansetron—Headache—Eplerenone—coronary artery disease	8.91e-05	0.000434	CcSEcCtD
Ondansetron—Nervous system disorder—Ramipril—coronary artery disease	8.9e-05	0.000433	CcSEcCtD
Ondansetron—Anaphylactic shock—Timolol—coronary artery disease	8.87e-05	0.000432	CcSEcCtD
Ondansetron—Pruritus—Pravastatin—coronary artery disease	8.86e-05	0.000432	CcSEcCtD
Ondansetron—Loss of consciousness—Lisinopril—coronary artery disease	8.86e-05	0.000432	CcSEcCtD
Ondansetron—Tachycardia—Ramipril—coronary artery disease	8.85e-05	0.000431	CcSEcCtD
Ondansetron—Skin disorder—Ramipril—coronary artery disease	8.81e-05	0.000429	CcSEcCtD
Ondansetron—Vomiting—Simvastatin—coronary artery disease	8.81e-05	0.000429	CcSEcCtD
Ondansetron—Hypersensitivity—Telmisartan—coronary artery disease	8.8e-05	0.000429	CcSEcCtD
Ondansetron—Cough—Lisinopril—coronary artery disease	8.8e-05	0.000429	CcSEcCtD
Ondansetron—Rash—Simvastatin—coronary artery disease	8.73e-05	0.000426	CcSEcCtD
Ondansetron—Dermatitis—Simvastatin—coronary artery disease	8.73e-05	0.000425	CcSEcCtD
Ondansetron—Asthenia—Trandolapril—coronary artery disease	8.73e-05	0.000425	CcSEcCtD
Ondansetron—Shock—Timolol—coronary artery disease	8.73e-05	0.000425	CcSEcCtD
Ondansetron—Feeling abnormal—Losartan—coronary artery disease	8.72e-05	0.000425	CcSEcCtD
Ondansetron—Urticaria—Furosemide—coronary artery disease	8.71e-05	0.000424	CcSEcCtD
Ondansetron—Diarrhoea—Niacin—coronary artery disease	8.7e-05	0.000424	CcSEcCtD
Ondansetron—Nervous system disorder—Timolol—coronary artery disease	8.7e-05	0.000424	CcSEcCtD
Ondansetron—Asthenia—Enalapril—coronary artery disease	8.69e-05	0.000423	CcSEcCtD
Ondansetron—Headache—Simvastatin—coronary artery disease	8.68e-05	0.000423	CcSEcCtD
Ondansetron—Body temperature increased—Furosemide—coronary artery disease	8.67e-05	0.000422	CcSEcCtD
Ondansetron—Abdominal pain—Furosemide—coronary artery disease	8.67e-05	0.000422	CcSEcCtD
Ondansetron—Gastrointestinal pain—Losartan—coronary artery disease	8.65e-05	0.000422	CcSEcCtD
Ondansetron—Dizziness—Valsartan—coronary artery disease	8.65e-05	0.000421	CcSEcCtD
Ondansetron—Skin disorder—Timolol—coronary artery disease	8.61e-05	0.00042	CcSEcCtD
Ondansetron—Dizziness—Olmesartan—coronary artery disease	8.61e-05	0.000419	CcSEcCtD
Ondansetron—Pruritus—Trandolapril—coronary artery disease	8.6e-05	0.000419	CcSEcCtD
Ondansetron—Chest pain—Lisinopril—coronary artery disease	8.58e-05	0.000418	CcSEcCtD
Ondansetron—Asthenia—Telmisartan—coronary artery disease	8.57e-05	0.000418	CcSEcCtD
Ondansetron—Pruritus—Enalapril—coronary artery disease	8.57e-05	0.000418	CcSEcCtD
Ondansetron—Diarrhoea—Pravastatin—coronary artery disease	8.57e-05	0.000418	CcSEcCtD
Ondansetron—Anxiety—Lisinopril—coronary artery disease	8.55e-05	0.000417	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	8.52e-05	0.000415	CcSEcCtD
Ondansetron—Discomfort—Lisinopril—coronary artery disease	8.48e-05	0.000413	CcSEcCtD
Ondansetron—Hypotension—Ramipril—coronary artery disease	8.48e-05	0.000413	CcSEcCtD
Ondansetron—Pruritus—Telmisartan—coronary artery disease	8.45e-05	0.000412	CcSEcCtD
Ondansetron—Dizziness—Niacin—coronary artery disease	8.41e-05	0.00041	CcSEcCtD
Ondansetron—Urticaria—Losartan—coronary artery disease	8.41e-05	0.00041	CcSEcCtD
Ondansetron—Dry mouth—Lisinopril—coronary artery disease	8.39e-05	0.000409	CcSEcCtD
Ondansetron—Body temperature increased—Losartan—coronary artery disease	8.36e-05	0.000408	CcSEcCtD
Ondansetron—Abdominal pain—Losartan—coronary artery disease	8.36e-05	0.000408	CcSEcCtD
Ondansetron—Asthenia—Captopril—coronary artery disease	8.34e-05	0.000406	CcSEcCtD
Ondansetron—Diarrhoea—Trandolapril—coronary artery disease	8.32e-05	0.000405	CcSEcCtD
Ondansetron—Vomiting—Valsartan—coronary artery disease	8.32e-05	0.000405	CcSEcCtD
Ondansetron—Diarrhoea—Enalapril—coronary artery disease	8.29e-05	0.000404	CcSEcCtD
Ondansetron—Hypotension—Timolol—coronary artery disease	8.29e-05	0.000404	CcSEcCtD
Ondansetron—Dizziness—Pravastatin—coronary artery disease	8.28e-05	0.000404	CcSEcCtD
Ondansetron—Vomiting—Olmesartan—coronary artery disease	8.28e-05	0.000403	CcSEcCtD
Ondansetron—Rash—Valsartan—coronary artery disease	8.25e-05	0.000402	CcSEcCtD
Ondansetron—Dermatitis—Valsartan—coronary artery disease	8.24e-05	0.000402	CcSEcCtD
Ondansetron—Anaphylactic shock—Lisinopril—coronary artery disease	8.23e-05	0.000401	CcSEcCtD
Ondansetron—Pruritus—Captopril—coronary artery disease	8.22e-05	0.0004	CcSEcCtD
Ondansetron—Rash—Olmesartan—coronary artery disease	8.21e-05	0.0004	CcSEcCtD
Ondansetron—Dermatitis—Olmesartan—coronary artery disease	8.2e-05	0.0004	CcSEcCtD
Ondansetron—Headache—Valsartan—coronary artery disease	8.2e-05	0.000399	CcSEcCtD
Ondansetron—Diarrhoea—Telmisartan—coronary artery disease	8.17e-05	0.000398	CcSEcCtD
Ondansetron—Headache—Olmesartan—coronary artery disease	8.16e-05	0.000397	CcSEcCtD
Ondansetron—Paraesthesia—Ramipril—coronary artery disease	8.15e-05	0.000397	CcSEcCtD
Ondansetron—Shock—Lisinopril—coronary artery disease	8.09e-05	0.000394	CcSEcCtD
Ondansetron—Asthenia—Perindopril—coronary artery disease	8.09e-05	0.000394	CcSEcCtD
Ondansetron—Dyspnoea—Ramipril—coronary artery disease	8.09e-05	0.000394	CcSEcCtD
Ondansetron—Vomiting—Niacin—coronary artery disease	8.09e-05	0.000394	CcSEcCtD
Ondansetron—Hypersensitivity—Furosemide—coronary artery disease	8.08e-05	0.000394	CcSEcCtD
Ondansetron—Somnolence—Ramipril—coronary artery disease	8.07e-05	0.000393	CcSEcCtD
Ondansetron—Dizziness—Trandolapril—coronary artery disease	8.04e-05	0.000392	CcSEcCtD
Ondansetron—Tachycardia—Lisinopril—coronary artery disease	8.03e-05	0.000391	CcSEcCtD
Ondansetron—Rash—Niacin—coronary artery disease	8.02e-05	0.000391	CcSEcCtD
Ondansetron—Dermatitis—Niacin—coronary artery disease	8.01e-05	0.00039	CcSEcCtD
Ondansetron—Dizziness—Enalapril—coronary artery disease	8.01e-05	0.00039	CcSEcCtD
Ondansetron—Skin disorder—Lisinopril—coronary artery disease	7.99e-05	0.000389	CcSEcCtD
Ondansetron—Pruritus—Perindopril—coronary artery disease	7.98e-05	0.000389	CcSEcCtD
Ondansetron—Headache—Niacin—coronary artery disease	7.97e-05	0.000388	CcSEcCtD
Ondansetron—Paraesthesia—Timolol—coronary artery disease	7.96e-05	0.000388	CcSEcCtD
Ondansetron—Vomiting—Pravastatin—coronary artery disease	7.96e-05	0.000388	CcSEcCtD
Ondansetron—Diarrhoea—Captopril—coronary artery disease	7.95e-05	0.000387	CcSEcCtD
Ondansetron—Dyspnoea—Timolol—coronary artery disease	7.91e-05	0.000385	CcSEcCtD
Ondansetron—Dizziness—Telmisartan—coronary artery disease	7.9e-05	0.000385	CcSEcCtD
Ondansetron—Rash—Pravastatin—coronary artery disease	7.9e-05	0.000385	CcSEcCtD
Ondansetron—Dermatitis—Pravastatin—coronary artery disease	7.89e-05	0.000384	CcSEcCtD
Ondansetron—Somnolence—Timolol—coronary artery disease	7.88e-05	0.000384	CcSEcCtD
Ondansetron—Asthenia—Furosemide—coronary artery disease	7.87e-05	0.000383	CcSEcCtD
Ondansetron—Headache—Pravastatin—coronary artery disease	7.85e-05	0.000382	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Ramipril—coronary artery disease	7.83e-05	0.000382	CcSEcCtD
Ondansetron—Fatigue—Ramipril—coronary artery disease	7.82e-05	0.000381	CcSEcCtD
Ondansetron—Hypersensitivity—Losartan—coronary artery disease	7.8e-05	0.00038	CcSEcCtD
Ondansetron—Pruritus—Furosemide—coronary artery disease	7.76e-05	0.000378	CcSEcCtD
Ondansetron—Constipation—Ramipril—coronary artery disease	7.76e-05	0.000378	CcSEcCtD
Ondansetron—Vomiting—Trandolapril—coronary artery disease	7.73e-05	0.000377	CcSEcCtD
Ondansetron—Diarrhoea—Perindopril—coronary artery disease	7.72e-05	0.000376	CcSEcCtD
Ondansetron—Vomiting—Enalapril—coronary artery disease	7.7e-05	0.000375	CcSEcCtD
Ondansetron—Hypotension—Lisinopril—coronary artery disease	7.69e-05	0.000375	CcSEcCtD
Ondansetron—Dizziness—Captopril—coronary artery disease	7.68e-05	0.000374	CcSEcCtD
Ondansetron—Rash—Trandolapril—coronary artery disease	7.67e-05	0.000374	CcSEcCtD
Ondansetron—Dermatitis—Trandolapril—coronary artery disease	7.66e-05	0.000373	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Timolol—coronary artery disease	7.66e-05	0.000373	CcSEcCtD
Ondansetron—Fatigue—Timolol—coronary artery disease	7.65e-05	0.000373	CcSEcCtD
Ondansetron—Rash—Enalapril—coronary artery disease	7.64e-05	0.000372	CcSEcCtD
Ondansetron—Dermatitis—Enalapril—coronary artery disease	7.63e-05	0.000372	CcSEcCtD
Ondansetron—Headache—Trandolapril—coronary artery disease	7.62e-05	0.000371	CcSEcCtD
Ondansetron—Vomiting—Telmisartan—coronary artery disease	7.6e-05	0.00037	CcSEcCtD
Ondansetron—Asthenia—Losartan—coronary artery disease	7.59e-05	0.00037	CcSEcCtD
Ondansetron—Headache—Enalapril—coronary artery disease	7.59e-05	0.00037	CcSEcCtD
Ondansetron—Pain—Timolol—coronary artery disease	7.58e-05	0.00037	CcSEcCtD
Ondansetron—Rash—Telmisartan—coronary artery disease	7.53e-05	0.000367	CcSEcCtD
Ondansetron—Dermatitis—Telmisartan—coronary artery disease	7.53e-05	0.000367	CcSEcCtD
Ondansetron—Diarrhoea—Furosemide—coronary artery disease	7.5e-05	0.000366	CcSEcCtD
Ondansetron—Pruritus—Losartan—coronary artery disease	7.49e-05	0.000365	CcSEcCtD
Ondansetron—Headache—Telmisartan—coronary artery disease	7.48e-05	0.000365	CcSEcCtD
Ondansetron—Feeling abnormal—Ramipril—coronary artery disease	7.48e-05	0.000364	CcSEcCtD
Ondansetron—Dizziness—Perindopril—coronary artery disease	7.46e-05	0.000363	CcSEcCtD
Ondansetron—Gastrointestinal pain—Ramipril—coronary artery disease	7.42e-05	0.000361	CcSEcCtD
Ondansetron—Paraesthesia—Lisinopril—coronary artery disease	7.39e-05	0.00036	CcSEcCtD
Ondansetron—Vomiting—Captopril—coronary artery disease	7.39e-05	0.00036	CcSEcCtD
Ondansetron—Dyspnoea—Lisinopril—coronary artery disease	7.34e-05	0.000357	CcSEcCtD
Ondansetron—Rash—Captopril—coronary artery disease	7.33e-05	0.000357	CcSEcCtD
Ondansetron—Dermatitis—Captopril—coronary artery disease	7.32e-05	0.000357	CcSEcCtD
Ondansetron—Somnolence—Lisinopril—coronary artery disease	7.31e-05	0.000356	CcSEcCtD
Ondansetron—Feeling abnormal—Timolol—coronary artery disease	7.31e-05	0.000356	CcSEcCtD
Ondansetron—Headache—Captopril—coronary artery disease	7.28e-05	0.000355	CcSEcCtD
Ondansetron—Gastrointestinal pain—Timolol—coronary artery disease	7.25e-05	0.000353	CcSEcCtD
Ondansetron—Dizziness—Furosemide—coronary artery disease	7.25e-05	0.000353	CcSEcCtD
Ondansetron—Diarrhoea—Losartan—coronary artery disease	7.24e-05	0.000353	CcSEcCtD
Ondansetron—Urticaria—Ramipril—coronary artery disease	7.21e-05	0.000351	CcSEcCtD
Ondansetron—Vomiting—Perindopril—coronary artery disease	7.17e-05	0.000349	CcSEcCtD
Ondansetron—Abdominal pain—Ramipril—coronary artery disease	7.17e-05	0.000349	CcSEcCtD
Ondansetron—Body temperature increased—Ramipril—coronary artery disease	7.17e-05	0.000349	CcSEcCtD
Ondansetron—Rash—Perindopril—coronary artery disease	7.11e-05	0.000347	CcSEcCtD
Ondansetron—Dermatitis—Perindopril—coronary artery disease	7.11e-05	0.000346	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Lisinopril—coronary artery disease	7.1e-05	0.000346	CcSEcCtD
Ondansetron—Fatigue—Lisinopril—coronary artery disease	7.09e-05	0.000346	CcSEcCtD
Ondansetron—Headache—Perindopril—coronary artery disease	7.07e-05	0.000344	CcSEcCtD
Ondansetron—Urticaria—Timolol—coronary artery disease	7.05e-05	0.000343	CcSEcCtD
Ondansetron—Pain—Lisinopril—coronary artery disease	7.04e-05	0.000343	CcSEcCtD
Ondansetron—Constipation—Lisinopril—coronary artery disease	7.04e-05	0.000343	CcSEcCtD
Ondansetron—Abdominal pain—Timolol—coronary artery disease	7.01e-05	0.000342	CcSEcCtD
Ondansetron—Body temperature increased—Timolol—coronary artery disease	7.01e-05	0.000342	CcSEcCtD
Ondansetron—Dizziness—Losartan—coronary artery disease	7e-05	0.000341	CcSEcCtD
Ondansetron—Vomiting—Furosemide—coronary artery disease	6.97e-05	0.00034	CcSEcCtD
Ondansetron—Rash—Furosemide—coronary artery disease	6.91e-05	0.000337	CcSEcCtD
Ondansetron—Dermatitis—Furosemide—coronary artery disease	6.91e-05	0.000337	CcSEcCtD
Ondansetron—Headache—Furosemide—coronary artery disease	6.87e-05	0.000335	CcSEcCtD
Ondansetron—Feeling abnormal—Lisinopril—coronary artery disease	6.78e-05	0.00033	CcSEcCtD
Ondansetron—Gastrointestinal pain—Lisinopril—coronary artery disease	6.73e-05	0.000328	CcSEcCtD
Ondansetron—Vomiting—Losartan—coronary artery disease	6.73e-05	0.000328	CcSEcCtD
Ondansetron—Hypersensitivity—Ramipril—coronary artery disease	6.68e-05	0.000326	CcSEcCtD
Ondansetron—Rash—Losartan—coronary artery disease	6.67e-05	0.000325	CcSEcCtD
Ondansetron—Dermatitis—Losartan—coronary artery disease	6.66e-05	0.000325	CcSEcCtD
Ondansetron—Headache—Losartan—coronary artery disease	6.63e-05	0.000323	CcSEcCtD
Ondansetron—Urticaria—Lisinopril—coronary artery disease	6.54e-05	0.000318	CcSEcCtD
Ondansetron—Hypersensitivity—Timolol—coronary artery disease	6.53e-05	0.000318	CcSEcCtD
Ondansetron—Asthenia—Ramipril—coronary artery disease	6.51e-05	0.000317	CcSEcCtD
Ondansetron—Abdominal pain—Lisinopril—coronary artery disease	6.5e-05	0.000317	CcSEcCtD
Ondansetron—Body temperature increased—Lisinopril—coronary artery disease	6.5e-05	0.000317	CcSEcCtD
Ondansetron—Pruritus—Ramipril—coronary artery disease	6.42e-05	0.000313	CcSEcCtD
Ondansetron—Asthenia—Timolol—coronary artery disease	6.36e-05	0.00031	CcSEcCtD
Ondansetron—Pruritus—Timolol—coronary artery disease	6.27e-05	0.000306	CcSEcCtD
Ondansetron—Diarrhoea—Ramipril—coronary artery disease	6.21e-05	0.000302	CcSEcCtD
Ondansetron—Diarrhoea—Timolol—coronary artery disease	6.07e-05	0.000296	CcSEcCtD
Ondansetron—Hypersensitivity—Lisinopril—coronary artery disease	6.06e-05	0.000295	CcSEcCtD
Ondansetron—Dizziness—Ramipril—coronary artery disease	6e-05	0.000292	CcSEcCtD
Ondansetron—Asthenia—Lisinopril—coronary artery disease	5.9e-05	0.000288	CcSEcCtD
Ondansetron—Dizziness—Timolol—coronary artery disease	5.86e-05	0.000286	CcSEcCtD
Ondansetron—Pruritus—Lisinopril—coronary artery disease	5.82e-05	0.000284	CcSEcCtD
Ondansetron—Vomiting—Ramipril—coronary artery disease	5.77e-05	0.000281	CcSEcCtD
Ondansetron—Rash—Ramipril—coronary artery disease	5.72e-05	0.000279	CcSEcCtD
Ondansetron—Dermatitis—Ramipril—coronary artery disease	5.71e-05	0.000278	CcSEcCtD
Ondansetron—Headache—Ramipril—coronary artery disease	5.68e-05	0.000277	CcSEcCtD
Ondansetron—Vomiting—Timolol—coronary artery disease	5.64e-05	0.000275	CcSEcCtD
Ondansetron—Diarrhoea—Lisinopril—coronary artery disease	5.63e-05	0.000274	CcSEcCtD
Ondansetron—Rash—Timolol—coronary artery disease	5.59e-05	0.000272	CcSEcCtD
Ondansetron—Dermatitis—Timolol—coronary artery disease	5.59e-05	0.000272	CcSEcCtD
Ondansetron—Headache—Timolol—coronary artery disease	5.56e-05	0.000271	CcSEcCtD
Ondansetron—Dizziness—Lisinopril—coronary artery disease	5.44e-05	0.000265	CcSEcCtD
Ondansetron—Vomiting—Lisinopril—coronary artery disease	5.23e-05	0.000255	CcSEcCtD
Ondansetron—Rash—Lisinopril—coronary artery disease	5.19e-05	0.000253	CcSEcCtD
Ondansetron—Dermatitis—Lisinopril—coronary artery disease	5.18e-05	0.000253	CcSEcCtD
Ondansetron—Headache—Lisinopril—coronary artery disease	5.15e-05	0.000251	CcSEcCtD
Ondansetron—HTR1A—Signaling Pathways—APOE—coronary artery disease	3.51e-06	2.92e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—FGF2—coronary artery disease	3.5e-06	2.91e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GSTA1—coronary artery disease	3.5e-06	2.91e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—POMC—coronary artery disease	3.49e-06	2.9e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CREB1—coronary artery disease	3.49e-06	2.9e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—SLC9A1—coronary artery disease	3.47e-06	2.89e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GSTT1—coronary artery disease	3.47e-06	2.89e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—APOA1—coronary artery disease	3.47e-06	2.88e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—LPA—coronary artery disease	3.46e-06	2.87e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—NOS3—coronary artery disease	3.45e-06	2.87e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—KDR—coronary artery disease	3.44e-06	2.86e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GCLC—coronary artery disease	3.43e-06	2.85e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CETP—coronary artery disease	3.43e-06	2.85e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—CD36—coronary artery disease	3.43e-06	2.85e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—CD36—coronary artery disease	3.43e-06	2.85e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CCL2—coronary artery disease	3.42e-06	2.84e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—MAPK14—coronary artery disease	3.41e-06	2.84e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IL6R—coronary artery disease	3.41e-06	2.83e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—SDC1—coronary artery disease	3.4e-06	2.82e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PPP2CA—coronary artery disease	3.39e-06	2.82e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PPP2CA—coronary artery disease	3.38e-06	2.81e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PLCB1—coronary artery disease	3.37e-06	2.8e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IGF1—coronary artery disease	3.36e-06	2.79e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—JAK2—coronary artery disease	3.35e-06	2.79e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—ESR1—coronary artery disease	3.35e-06	2.78e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PLCB3—coronary artery disease	3.35e-06	2.78e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—MAPK1—coronary artery disease	3.34e-06	2.78e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PLCB1—coronary artery disease	3.34e-06	2.78e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—APOA5—coronary artery disease	3.31e-06	2.76e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—FN1—coronary artery disease	3.31e-06	2.75e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—F2—coronary artery disease	3.31e-06	2.75e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IL6ST—coronary artery disease	3.3e-06	2.74e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—PIK3CA—coronary artery disease	3.29e-06	2.73e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	3.28e-06	2.72e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—ALB—coronary artery disease	3.27e-06	2.72e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—NFKBIA—coronary artery disease	3.27e-06	2.72e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—ABCA1—coronary artery disease	3.27e-06	2.72e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—MTHFR—coronary artery disease	3.25e-06	2.7e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—P4HB—coronary artery disease	3.25e-06	2.7e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—MTHFR—coronary artery disease	3.25e-06	2.7e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—ABCA1—coronary artery disease	3.24e-06	2.69e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PSMA6—coronary artery disease	3.21e-06	2.67e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PSMB5—coronary artery disease	3.21e-06	2.67e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	3.2e-06	2.66e-05	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	3.19e-06	2.66e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	3.19e-06	2.65e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—SERPINE1—coronary artery disease	3.19e-06	2.65e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—KIT—coronary artery disease	3.17e-06	2.63e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GOT1—coronary artery disease	3.16e-06	2.63e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GGT1—coronary artery disease	3.16e-06	2.63e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GGT1—coronary artery disease	3.14e-06	2.61e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GOT1—coronary artery disease	3.14e-06	2.61e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CTGF—coronary artery disease	3.13e-06	2.6e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—NOS3—coronary artery disease	3.13e-06	2.6e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—HMGCR—coronary artery disease	3.11e-06	2.58e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GOT2—coronary artery disease	3.11e-06	2.58e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—AGT—coronary artery disease	3.09e-06	2.57e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—FGF2—coronary artery disease	3.09e-06	2.57e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—AGT—coronary artery disease	3.08e-06	2.56e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CXCL8—coronary artery disease	3.06e-06	2.54e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—NOS3—coronary artery disease	3.05e-06	2.53e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—GSK3B—coronary artery disease	3.04e-06	2.53e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—APOE—coronary artery disease	3.03e-06	2.52e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—APOE—coronary artery disease	3.02e-06	2.51e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—POMC—coronary artery disease	3.01e-06	2.51e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CREB1—coronary artery disease	3.01e-06	2.51e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—VCAN—coronary artery disease	3.01e-06	2.5e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—APOA1—coronary artery disease	2.99e-06	2.49e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—APOA1—coronary artery disease	2.99e-06	2.48e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ALDOA—coronary artery disease	2.98e-06	2.48e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—JAK2—coronary artery disease	2.96e-06	2.46e-05	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—AKT1—coronary artery disease	2.96e-06	2.46e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CCL2—coronary artery disease	2.95e-06	2.45e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IL6R—coronary artery disease	2.94e-06	2.44e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CASP3—coronary artery disease	2.93e-06	2.44e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—IL6—coronary artery disease	2.91e-06	2.42e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—PIK3CA—coronary artery disease	2.9e-06	2.41e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IGF1—coronary artery disease	2.9e-06	2.41e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—DCN—coronary artery disease	2.9e-06	2.41e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—MAPK1—coronary artery disease	2.89e-06	2.4e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PTGS2—coronary artery disease	2.86e-06	2.38e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PLCB1—coronary artery disease	2.86e-06	2.37e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CCND1—coronary artery disease	2.85e-06	2.37e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GSTP1—coronary artery disease	2.84e-06	2.36e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ALDH2—coronary artery disease	2.82e-06	2.34e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GSTP1—coronary artery disease	2.82e-06	2.34e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	2.82e-06	2.34e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—HMOX1—coronary artery disease	2.8e-06	2.33e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	2.8e-06	2.33e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	2.79e-06	2.32e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—HMOX1—coronary artery disease	2.78e-06	2.31e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—MMP9—coronary artery disease	2.77e-06	2.3e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ABCA1—coronary artery disease	2.77e-06	2.3e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CAT—coronary artery disease	2.77e-06	2.3e-05	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—PIK3CA—coronary artery disease	2.76e-06	2.29e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—SERPINE1—coronary artery disease	2.75e-06	2.29e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—LIPC—coronary artery disease	2.75e-06	2.28e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—HBA1—coronary artery disease	2.75e-06	2.28e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CYP2C19—coronary artery disease	2.75e-06	2.28e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	2.75e-06	2.28e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CAT—coronary artery disease	2.74e-06	2.28e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—APOC3—coronary artery disease	2.73e-06	2.27e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—LDLR—coronary artery disease	2.71e-06	2.26e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CXCL8—coronary artery disease	2.7e-06	2.25e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—AKT1—coronary artery disease	2.68e-06	2.23e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—APOB—coronary artery disease	2.68e-06	2.23e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GSTT1—coronary artery disease	2.68e-06	2.23e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—SLC9A1—coronary artery disease	2.68e-06	2.23e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GGT1—coronary artery disease	2.68e-06	2.23e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GOT1—coronary artery disease	2.68e-06	2.23e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—FGF2—coronary artery disease	2.67e-06	2.22e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—APOB—coronary artery disease	2.66e-06	2.21e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GCLC—coronary artery disease	2.65e-06	2.2e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CETP—coronary artery disease	2.65e-06	2.2e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PPARG—coronary artery disease	2.64e-06	2.19e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PPARG—coronary artery disease	2.63e-06	2.19e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—NOS3—coronary artery disease	2.63e-06	2.18e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—SDC1—coronary artery disease	2.62e-06	2.18e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GSTM1—coronary artery disease	2.61e-06	2.17e-05	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—AKT1—coronary artery disease	2.61e-06	2.17e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—POMC—coronary artery disease	2.6e-06	2.16e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—POMC—coronary artery disease	2.6e-06	2.16e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GSTM1—coronary artery disease	2.59e-06	2.15e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CASP3—coronary artery disease	2.59e-06	2.15e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—IL6—coronary artery disease	2.57e-06	2.14e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—LPL—coronary artery disease	2.56e-06	2.13e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—JAK2—coronary artery disease	2.55e-06	2.12e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—LPL—coronary artery disease	2.54e-06	2.11e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CCND1—coronary artery disease	2.52e-06	2.09e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—PIK3CA—coronary artery disease	2.5e-06	2.08e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GPX1—coronary artery disease	2.5e-06	2.08e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—VEGFA—coronary artery disease	2.49e-06	2.07e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GPX1—coronary artery disease	2.48e-06	2.06e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PSMB5—coronary artery disease	2.48e-06	2.06e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PSMA6—coronary artery disease	2.48e-06	2.06e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—MMP9—coronary artery disease	2.44e-06	2.03e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CD36—coronary artery disease	2.44e-06	2.02e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CTGF—coronary artery disease	2.42e-06	2.01e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CD36—coronary artery disease	2.41e-06	2.01e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GSTP1—coronary artery disease	2.41e-06	2e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PPP2CA—coronary artery disease	2.41e-06	2e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—HMGCR—coronary artery disease	2.4e-06	1.99e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GOT2—coronary artery disease	2.4e-06	1.99e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	2.39e-06	1.98e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PPP2CA—coronary artery disease	2.38e-06	1.98e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—HMOX1—coronary artery disease	2.37e-06	1.97e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—ALB—coronary artery disease	2.37e-06	1.97e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—AKT1—coronary artery disease	2.37e-06	1.97e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—ALB—coronary artery disease	2.37e-06	1.97e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CAT—coronary artery disease	2.34e-06	1.95e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CXCL8—coronary artery disease	2.33e-06	1.94e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—MTHFR—coronary artery disease	2.31e-06	1.92e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—MTHFR—coronary artery disease	2.29e-06	1.9e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—TGFB1—coronary artery disease	2.28e-06	1.9e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—APOB—coronary artery disease	2.27e-06	1.89e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—NOS3—coronary artery disease	2.27e-06	1.89e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—NOS3—coronary artery disease	2.26e-06	1.88e-05	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—AKT1—coronary artery disease	2.25e-06	1.87e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—MAPK1—coronary artery disease	2.24e-06	1.86e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CASP3—coronary artery disease	2.23e-06	1.86e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—IL6—coronary artery disease	2.22e-06	1.84e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GSTM1—coronary artery disease	2.21e-06	1.84e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.2e-06	1.83e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—VEGFA—coronary artery disease	2.19e-06	1.82e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—AGT—coronary artery disease	2.19e-06	1.82e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—AGT—coronary artery disease	2.17e-06	1.81e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CCND1—coronary artery disease	2.17e-06	1.81e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—LPL—coronary artery disease	2.17e-06	1.81e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—APOE—coronary artery disease	2.15e-06	1.79e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.14e-06	1.78e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—APOE—coronary artery disease	2.13e-06	1.77e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—APOA1—coronary artery disease	2.12e-06	1.77e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GPX1—coronary artery disease	2.12e-06	1.76e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—MMP9—coronary artery disease	2.11e-06	1.75e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—APOA1—coronary artery disease	2.11e-06	1.75e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PTGS2—coronary artery disease	2.07e-06	1.72e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PTGS2—coronary artery disease	2.07e-06	1.72e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GOT1—coronary artery disease	2.07e-06	1.72e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GGT1—coronary artery disease	2.07e-06	1.72e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CD36—coronary artery disease	2.06e-06	1.72e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—AKT1—coronary artery disease	2.05e-06	1.7e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PPP2CA—coronary artery disease	2.04e-06	1.69e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.02e-06	1.68e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—TGFB1—coronary artery disease	2.01e-06	1.67e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—MAPK1—coronary artery disease	1.97e-06	1.64e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—MTHFR—coronary artery disease	1.96e-06	1.63e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—PIK3CA—coronary artery disease	1.94e-06	1.61e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—VEGFA—coronary artery disease	1.89e-06	1.57e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PPARG—coronary artery disease	1.87e-06	1.56e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.86e-06	1.54e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—AGT—coronary artery disease	1.86e-06	1.54e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PPARG—coronary artery disease	1.86e-06	1.54e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—POMC—coronary artery disease	1.85e-06	1.53e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.84e-06	1.53e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.83e-06	1.52e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—POMC—coronary artery disease	1.83e-06	1.52e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—APOE—coronary artery disease	1.82e-06	1.51e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CAT—coronary artery disease	1.81e-06	1.5e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—APOA1—coronary artery disease	1.8e-06	1.5e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PIK3CA—coronary artery disease	1.76e-06	1.47e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—APOB—coronary artery disease	1.76e-06	1.46e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—TGFB1—coronary artery disease	1.74e-06	1.44e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.72e-06	1.43e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IL6—coronary artery disease	1.72e-06	1.43e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PIK3CA—coronary artery disease	1.71e-06	1.42e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.71e-06	1.42e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—MAPK1—coronary artery disease	1.7e-06	1.42e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—ALB—coronary artery disease	1.68e-06	1.4e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—LPL—coronary artery disease	1.68e-06	1.39e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—ALB—coronary artery disease	1.67e-06	1.39e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GPX1—coronary artery disease	1.64e-06	1.36e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—NOS3—coronary artery disease	1.61e-06	1.34e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—NOS3—coronary artery disease	1.6e-06	1.33e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CD36—coronary artery disease	1.59e-06	1.32e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—AKT1—coronary artery disease	1.59e-06	1.32e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PPARG—coronary artery disease	1.59e-06	1.32e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.57e-06	1.31e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—POMC—coronary artery disease	1.56e-06	1.3e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IL6—coronary artery disease	1.52e-06	1.26e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.51e-06	1.25e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PIK3CA—coronary artery disease	1.48e-06	1.23e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.47e-06	1.22e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PTGS2—coronary artery disease	1.46e-06	1.21e-05	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—AKT1—coronary artery disease	1.44e-06	1.2e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—AGT—coronary artery disease	1.43e-06	1.19e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ALB—coronary artery disease	1.43e-06	1.19e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—APOE—coronary artery disease	1.4e-06	1.17e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—AKT1—coronary artery disease	1.4e-06	1.16e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—APOA1—coronary artery disease	1.39e-06	1.15e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—NOS3—coronary artery disease	1.36e-06	1.13e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IL6—coronary artery disease	1.31e-06	1.09e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PIK3CA—coronary artery disease	1.28e-06	1.06e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PIK3CA—coronary artery disease	1.27e-06	1.06e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PTGS2—coronary artery disease	1.25e-06	1.04e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PPARG—coronary artery disease	1.22e-06	1.02e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—AKT1—coronary artery disease	1.21e-06	1e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—POMC—coronary artery disease	1.21e-06	1e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ALB—coronary artery disease	1.1e-06	9.15e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—NOS3—coronary artery disease	1.05e-06	8.75e-06	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—AKT1—coronary artery disease	1.04e-06	8.67e-06	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—AKT1—coronary artery disease	1.04e-06	8.65e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PTGS2—coronary artery disease	9.63e-07	8e-06	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PIK3CA—coronary artery disease	9.06e-07	7.53e-06	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PIK3CA—coronary artery disease	8.98e-07	7.47e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PIK3CA—coronary artery disease	7.67e-07	6.38e-06	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—AKT1—coronary artery disease	7.4e-07	6.15e-06	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—AKT1—coronary artery disease	7.34e-07	6.1e-06	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—AKT1—coronary artery disease	6.27e-07	5.21e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PIK3CA—coronary artery disease	5.92e-07	4.92e-06	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—AKT1—coronary artery disease	4.84e-07	4.02e-06	CbGpPWpGaD
